Trending News

Changes to Civil Rights Enforcement: New Executive Order Eliminates Disparate-Impact Liability in Federal Regulations

GlobeNewswire Biotech

Website

www.globenewswire.com

Featured Biotech Press Releases From GlobeNewswire

Onconetix Announces New Clinical Data for its Innovative Prostate Cancer Test Proclarix Accepted for Presentation at 2025 European Association of Urology Congress
Posted On Wednesday, March 19, 2025
Cidara Therapeutics to Participate in World Health Organization Meeting on H5N1 Influenza Preparedness and Response
Posted On Wednesday, March 19, 2025
BioAtla to Announce Fourth Quarter and Full-Year 2024 Financial Results and Provide Business Highlights on March 27, 2025
Posted On Wednesday, March 19, 2025
Acumen Pharmaceuticals Announces Topline Results from Phase 1 Study of Subcutaneous Formulation of Sabirnetug in Healthy Volunteers
Posted On Wednesday, March 19, 2025
Immunovant Announces Positive Results for Batoclimab Myasthenia Gravis (MG) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Studies
Posted On Wednesday, March 19, 2025
Roivant Announces Positive Results for Batoclimab Myasthenia Gravis (MG) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Studies
Posted On Wednesday, March 19, 2025
Plus Therapeutics to Announce Fourth Quarter and Full Year 2024 Financial Results and Host Conference Call on March 27, 2025
Posted On Wednesday, March 19, 2025
Cronos Appoints Anna Shlimak as Chief Financial Officer
Posted On Wednesday, March 19, 2025
Atea Pharmaceuticals Announces Presentation of Bemnifosbuvir Preclinical Data at the 38th International Conference on Antiviral Research (ICAR) 2025
Posted On Wednesday, March 19, 2025
Oragenics, Inc. Announces Filing of 2024 Annual Report on Form 10-K
Posted On Tuesday, March 18, 2025
Cytek® Biosciences Expands Cell Analysis Offerings with the Affordable, User-Friendly Cytek® Muse® Micro System
Posted On Tuesday, March 18, 2025
BioSyent Announces Grant of Restricted Share Units
Posted On Tuesday, March 18, 2025
Immunovant to Host Investor Webcast at 8:00 AM ET on Wednesday, March 19 to Review Results from Batoclimab Myasthenia Gravis (MG) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Programs
Posted On Tuesday, March 18, 2025
Roivant to Host Investor Webcast at 8:00 AM ET on Wednesday, March 19 to Review Results from Batoclimab Myasthenia Gravis (MG) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Programs
Posted On Tuesday, March 18, 2025
Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights
Posted On Tuesday, March 18, 2025
CARGO Therapeutics Provides Corporate Update
Posted On Tuesday, March 18, 2025
Oncocyte to Release Fourth Quarter 2024 Results on March 24, 2025
Posted On Tuesday, March 18, 2025
Kronos Bio Reports Fourth Quarter and Full Year 2024 Financial Results
Posted On Tuesday, March 18, 2025
Mineralys Therapeutics Announces Closing of Underwriters’ Option to Purchase Additional Shares in Connection with Public Offering of Common Stock
Posted On Tuesday, March 18, 2025
BioAegis Therapeutics to Highlight Lead Product Gelsolin’s Critical Role in Immune Function at Upcoming Conferences
Posted On Tuesday, March 18, 2025
ZHITTYA GENESIS MEDICINE ANNOUNCES: DR. JACK JACOBS, PRESIDENT, TO RECEIVE NEVADABIO HONOR FOR PARKINSON’S DISEASE BREAKTHROUGH
Posted On Tuesday, March 18, 2025
Biofrontera Inc. Announces Completion of Patient Enrollment in Phase 3 Study of Ameluz® (aminolevulinic acid HCI) Topical Gel, 10% for the Treatment of Actinic Keratoses on the Extremities, Neck and Trunk
Posted On Tuesday, March 18, 2025
Iantrek Announces Positive 2-Year Results Demonstrating Efficacy and Safety of Its Bio-Interventional Technology for Uveoscleral Outflow Enhancement in Glaucoma Patients
Posted On Tuesday, March 18, 2025
GRI Bio Participates in a Virtual Investor CEO Connect Segment
Posted On Tuesday, March 18, 2025
Leading Academic and Manufacturing Organizations Join Ori Biotech’s Preferred Partner Network to Accelerate the Commercialization of Cell and Gene Therapies
Posted On Tuesday, March 18, 2025

Print